Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclavedLeishmania major+ BCG) in children: an extended phase II study-Reference-Cited by-同舟云学术

Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclavedLeishmania major+ BCG) in children: an extended phase II study

Published:2006-12 Issue:4 Volume:26 Page:357-361
ISSN:0272-4936
Container-title:Annals of Tropical Paediatrics
language:en
Short-container-title:Annals of Tropical Paediatrics

Author:

Khalil Eltahir Awad Gasim,Musa Ahmed Mudawi,Modabber Farroukh,El-Hassan Ahmed Mohamed

Publisher

Informa UK Limited

Subject

Pediatrics, Perinatology, and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1179/146532806X152890

Reference18 articles.

1. Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north

2. Experiences with vaccines against cutaneous leishmaniasis: of men and mice

3. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis;Molecular Therapy - Methods & Clinical Development;2024-09

2. Leishmania vaccine development: A comprehensive review;Cellular Immunology;2024-05

3. A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis;2024-04-11

4. Vaccine Development for Human Leishmaniasis;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023

5. Feasibility of Therapeutic Vaccine for the Management and Control of VL;Challenges and Solutions Against Visceral Leishmaniasis;2023